Autres langues GlaxoSmithKline Pakistan Limited

Actions

GLAXO

PK0001301016

Produits pharmaceutiques

Cours en clôture Pakistan S.E. 12/10/2026			Varia. 5j.	Varia. 1 janv.
312,00 ^PKR	-1,45%		+1,36%	-19,95%

03/09	GlaxoSmithKline Pakistan Limited annonce la nomination de Muhammad Yousuf Vohra au poste de directeur financier, à compter du 15 octobre 2026	CI
28/08	GlaxoSmithKline Pakistan Limited annonce la nomination de Muhammad Masood Ahmed Khan au poste de directeur exécutif, à compter du 28 août 2026	CI

Autres langues

03/09	GlaxoSmithKline Pakistan Limited Announces Appointment of Muhammad Yousuf Vohra as Chief Financial Officer, Effective October 15, 2026
03/09	GlaxoSmithKline Pakistan Limited Announces Appointment of Muhammad Yousuf Vohra as Finance Director, Effective October 15, 2026
28/08	GlaxoSmithKline Pakistan Limited Announces Appointment of Muhammad Masood Ahmed Khan to Executive Director, Effective August 28, 2026
25/08	GlaxoSmithKline Pakistan Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026
25/08	GlaxoSmithKline Pakistan Limited Interim Cash Dividend for the Half Year Ended June 30, 2026, Payable on September 11, 2026
03/08	GlaxoSmithKline Pakistan : Appointment of Interim/ Acting Chief Financial Officer
03/08	GlaxoSmithKline Pakistan : Appointment of Non-Executive Director
03/08	GlaxoSmithKline Pakistan Limited Appoints Umair Majeed as Interim/Acting Chief Financial Officer, Effective from July 30, 2026
03/08	GlaxoSmithKline Pakistan Limited Announces Appointment of Hasham Ali Baber as Non-Executive Director, Effective July 30, 2026
08/06	GlaxoSmithKline Pakistan Limited Announces Resignation of Hasham Baber as Chief Financial Officer, Effective June 30, 2026
08/06	GlaxoSmithKline Pakistan Limited Announces Resignation of Hasham Baber as Executive Director of the Board of Directors, Effective June 30, 2026
01/06	GlaxoSmithKline Pakistan : Resignation of Non-Executive Director
01/06	GlaxoSmithKline Pakistan Limited Announces Resignation of Ana Paula De Freitas Passos as Non-Executive Director, Effective May 31, 2026
25/05	GlaxoSmithKline Pakistan : (Re) Appointment of Chairperson and Chief Executive Officer
08/05	GlaxoSmithKline Pakistan : Video Recording of the Corporate Briefing Session
05/05	GlaxoSmithKline Pakistan : Presentation of the Corporate Briefing Session
30/04	GlaxoSmithKline Pakistan : Corporate Briefing Session
30/04	GlaxoSmithkline Pakistan Limited Approves Final Cash Dividend for the Year Ended 31 December, 2025
30/04	GlaxoSmithkline Pakistan Limited Approves Board Elections, Effective May 25, 2026
27/04	GlaxoSmithKline Pakistan Limited Reports Earnings Results for the First Quarter Ended March 31, 2026
20/04	GlaxoSmithKline Pakistan : Board Meeting Quarter 1- 2026
09/04	GlaxoSmithKline Pakistan : Transmission of Annual Financial Statements for the year ended 31-12-2025
09/04	GlaxoSmithKline Pakistan Limited Proposes Final Cash Dividend for the Financial Year Ended 31 December 2025
08/04	GlaxoSmithKline Pakistan : Prior Publication of Annual General Meeting Notice
07/04	GlaxoSmithKline Pakistan Limited Announces Board Changes